SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-027930
Filing Date
2017-04-28
Accepted
2017-04-28 16:21:34
Documents
5
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-11998_3defa14a.htm DEFA14A 32481
2 GRAPHIC g119983bci001.gif GRAPHIC 58109
3 GRAPHIC g119983bci002.gif GRAPHIC 88955
4 GRAPHIC g119983bci003.gif GRAPHIC 28088
5 GRAPHIC g119983bci004.gif GRAPHIC 4006
  Complete submission text file 0001104659-17-027930.txt   280808
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36306 | Film No.: 17795873
SIC: 2834 Pharmaceutical Preparations